Hutchison China Meditech LTD (HCM)


Latest News

Chi-Med presents pre-clinical data at ASH

Hutchison China MediTech says data from a recent pre-clinical study, investigating the in vitro and in vivo anti-tumor act...

HMPL-523 Pre-clinical Data Presented at ASH

RNS Number: 0314R Hutchison China Meditech Limited 06 December 2016 Press Release Chi-Med Presents Pre-clinical Data for Selective S yk Inhibitor HMPL-523 at the 2016 American Society of Hematology Annual Meeting London: Tuesday , December 6, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that data from a...

Exercise of Share Options

RNS Number: 5202Q Hutchison China Meditech Limited 30 November 2016 Exercise of Share Options by a Person Discharging Managerial Responsibilities London: Wednesday, November 30 , 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Dr Weiguo Su, Executive Vice President and Chief Scientific Officer...

Total Voting Rights

RNS Number: 5198Q Hutchison China Meditech Limited 30 November 2016 Total Voting Rights London: Wednesday , November 30, 2016: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at November 30, 2016, the issued share capital of Chi-Med consisted of 60,703,323 ordinary shares ...

All News

06-12-16Chi-Med presents pre-clinical data at ASHStockMarketWire
06-12-16HMPL-523 Pre-clinical Data Presented at ASHRNS
30-11-16Exercise of Share OptionsRNS
30-11-16Total Voting RightsRNS
23-11-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
23-11-16Director's Share DealingRNS
23-11-16Chi-Med to Present Data at the 17th WCLCRNS
23-11-16Chi-Med to Present Data at the at the 17th WCLCRNS
14-11-16Chi-Med to present clinical data at ACR/ARHP StockMarketWire
14-11-16Chi-Med Presents Ph I Clinical Data for HMPL-523RNS
01-11-16Director's Share DealingRNS
31-10-16Chi-Med JV gets $59.5m land compensation payment StockMarketWire
31-10-16Joint Venture - US$59.5m Land Compensation PaymentRNS
12-10-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
12-10-16Director's Share DealingRNS
16-09-16Broker Forecast - Panmure Gordon issues a broker note on Hutchison China Meditech LtdStockMarketWire
09-08-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
09-08-16Director's Share DealingRNS
02-08-16Change of Non-executive DirectorsRNS
02-08-16Chi-Med revenues rise StockMarketWire
02-08-16Chi-Med 2016 Interim ResultsRNS
01-08-16Chi-Med and AZ to accelerate savolitinibStockMarketWire
01-08-16Chi-Med and AstraZeneca to Accelerate SavolitinibRNS
12-07-16The best UK equity funds of 2016Money Observer
05-07-16Chi-Med to Announce 2016 HY Financial ResultsRNS
29-06-16Blocklisting Six Monthly ReturnRNS
27-06-16What are the safest places to store your money post-Brexit?Motley Fool
20-06-16Chi-Med initiation of phase II trial of savolitinib StockMarketWire
20-06-16Savolitinib Global Phase II Trial InitiatedRNS
15-06-16Additional ListingRNS
31-05-16Total Voting RightsRNS
13-05-16Chi-Med completes fruquintinib trial enrolment StockMarketWire
13-05-16Enrollment completion of Phase III fruquintinibRNS
29-04-16Total Voting RightsRNS
27-04-16Results of Annual General MeetingRNS
26-04-16Pharma fight! Should you buy GlaxoSmithKline plc, Smith & Nephew plc or Hutchison China MediTech Limited?Motley Fool
13-04-16Chi-Med over-allotment option exercisedStockMarketWire
13-04-16Exercise of Overallotment OptionRNS
12-04-16Chi-Med unit initiates clinical trial in AustraliaStockMarketWire
12-04-16Clinical trial of novel PI3K inhibitor HMPL-689RNS

RSS feeds

  • Editorial news feed for LSE:HCM Editorial
  • Regulatory news feed for LSE:HCM Regulatory